PD‐L1 that is expressed in cancer cells could specifically bind to the receptor (PD‐1) on the surface of activated T cells in the tumor microenvironment and transmit negative regulatory signals to inhibit T cell activation, proliferation or cytokine secretion [20, 21]. The gene discussed is CD274; the disease is neoplasm.